Index Management Solutions’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$8.6M Buy
145,807
+48,832
+50% +$8.91M 8.53% 1
2015
Q2
$7.98M Buy
96,975
+96,955
+484,775% +$16.7M 7.47% 1
2015
Q1
$3K Buy
20
+7
+54% +$1.27K ﹤0.01% 738
2014
Q4
$2K Sell
13
-22
-63% -$4.08K ﹤0.01% 776
2014
Q3
$6K Sell
35
-10
-22% -$1.64K ﹤0.01% 1056
2014
Q2
$7K Sell
45
-112
-71% -$17.7K ﹤0.01% 1048
2014
Q1
$24K Sell
157
-175
-53% -$27.8K ﹤0.01% 1055
2013
Q4
$44K Sell
332
-30
-8% -$3.6K 0.01% 549
2013
Q3
$42K Buy
+362
New +$39.7K 0.01% 537

Other funds holding ALXN

Index Management Solutions's ALXN Position: Q3 2015 in Review

Index Management Solutions increased its Alexion Pharmaceuticals (ALXN) stake by 50% in Q3 2015, buying an estimated $8.91M and bringing the position to 145,807 shares worth $8.6M. The position accounts for 8.53% of the portfolio, ranked #1.

Index Management Solutions first reported a position in ALXN in Q3 2013 and has held it in 9 quarters since. 513 funds tracked by Wall St. Rank hold ALXN as of Q3 2015.

  • Index Management Solutions held 145,807 shares of Alexion Pharmaceuticals worth $8.6M as of Q3 2015.
  • Index Management Solutions bought 48,832 Alexion Pharmaceuticals shares in Q3 2015, an estimated $8.91M.
  • Alexion Pharmaceuticals made up 8.53% of Index Management Solutions's portfolio in Q3 2015, its #1 holding.
  • Index Management Solutions first reported a position in Alexion Pharmaceuticals in Q3 2013 and has held it in 9 quarters since.
  • 513 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2015.

Based on Index Management Solutions's 13F filing for Q3 2015, filed 13 Nov 2015.